The Synergistic Effects of Hyaluronic Acid and Platelet-Rich Plasma for Patellar Chondropathy
Authors:
- Fábio Ramos CostaFCFábio Ramos Costa
- Márcia da Silva SantosMSMárcia da Silva Santos
- Rubens Andrade MartinsRMRubens Andrade Martins
- Cláudia Bruno CostaCCCláudia Bruno Costa
- Paulo César HamdanPHPaulo César Hamdan
- Marcos Britto Da SilvaMSMarcos Britto Da Silva
- Gabriel Ohana Marques AzziniGAGabriel Ohana Marques Azzini
- Luyddy PiresLPLuyddy Pires
- Zartur MenegassiZMZartur Menegassi
- Gabriel Silva SantosGabriel Silva Santos
- José Fábio LanaJLJosé Fábio Lana
Open Access
- 19 December 2023
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 12 (1) , 6
Abstract
Musculoskeletal disorders are increasingly prevalent worldwide, causing significant socioeconomic burdens and diminished quality of life. Notably, patellar chondropathy (PC) is among the most widespread conditions affecting joint structures, resulting in profound pain and disability. Hyaluronic acid (HA) and platelet-rich plasma (PRP) have emerged as reliable, effective, and minimally invasive alternatives. Continuous research spanning from laboratory settings to clinical applications demonstrates the numerous advantages of both products. These encompass lubrication, anti-inflammation, and stimulation of cellular behaviors linked to proliferation, differentiation, migration, and the release of essential growth factors. Cumulatively, these benefits support the rejuvenation of bone and cartilaginous tissues, which are otherwise compromised due to the prevailing degenerative and inflammatory responses characteristic of tissue damage. While existing literature delves into the physical, mechanical, and biological facets of these products, as well as their commercial variants and distinct clinical uses, there is limited discussion on their interconnected roles. We explore basic science concepts, product variations, and clinical strategies. This comprehensive examination provides physicians with an alternative insight into the pathophysiology of PC as well as biological mechanisms stimulated by both HA and PRP that contribute to tissue restoration.Keywords
All Related Versions
This publication has 138 references indexed in Scilit:
- Platelet-rich plasma in patients with tibiofemoral cartilage degenerationArchives of orthopaedic and trauma surgery, 2013
- In vitro response of osteoarthritic chondrocytes and fibroblast‐like synoviocytes to a 500–730 kDa hyaluronan amide derivativeJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2012
- Platelet‐Rich Plasma: A Milieu of Bioactive FactorsArthroscopy, 2012
- Platelet-Rich Plasma Releasate Inhibits Inflammatory Processes in Osteoarthritic ChondrocytesThe American Journal of Sports Medicine, 2011
- Intra-articular injections of hyaluronan solutions of different elastoviscosity reduce nociceptive nerve activity in a model of osteoarthritic knee joint of the guinea pigOsteoarthritis and Cartilage, 2009
- Osteoprotegerin inhibits cartilage degradation through an effect on trabecular bone in murine experimental osteoarthritisArthritis & Rheumatism, 2008
- Hepatocyte Growth Factor Exerts Its Anti-Inflammatory Action by Disrupting Nuclear Factor-κB SignalingThe American Journal of Pathology, 2008
- Platelets and wound healingFrontiers in Bioscience-Landmark, 2008
- Cytokines, Inflammation, and PainInternational Anesthesiology Clinics, 2007
- Effects of hyaluronan on nitric oxide levels and superoxide dismutase activities in synovial fluid in knee osteoarthritisClinical Rheumatology, 2006